Interestingly, while attention on EphB6 expression has been focused primarily on primary tumor samples, our analysis shows that EPHB6 mRNA is upregulated in metastatic compared to primary lesions in estrogen-positive breast cancer patients (Figure 2E). Here, EPHB6 is linked to breast cancer.